---
$id: https://graph.org.ai/products/commodity/51201813
$type: Product
source: UNSPSC
code: "51201813"
title: "Betazole"
class: "51201800"
classTitle: "Immunostimulating agents"
family: "51200000"
familyTitle: "Immunomodulating drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Betazole

**UNSPSC Code**: 51201813
**Class**: [Immunostimulating agents](Immunostimulating agents.mdx)
**Family**: [Immunomodulating drugs](../Immunomodulating drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a diagnostic reagent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1C065P542O. European Medicines Agency schedules Betazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05805MIG. Betazole generally arises in the molecular formula C5H9N3. The term BETAZOLE is an International Non-Proprietary Name or INN. BETAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule betazole under HS 29331990 and SITC 51571. As of Q4 2014, BETAZOLE remains the US FDA Preferred Term for this commodity. Betazole bears US NLM identifiers UMLS ID C0005321 and NCI Concept Code C65258. SMILES: C1=C(NN=C1)CCN.

